Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.1.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.1.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.1.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.49EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.49EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.49ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.49ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.49EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.49EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.49ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.49ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBL.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBL.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBL.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBL.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBL.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBL.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FR.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FR.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FR.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FR.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FR.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FR.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FR.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.17ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.17EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used